Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IDEC-Y2B8/IDEC-C2B8 combination undergoes phase I/II

Aug. 23, 1996

Fareston launched in the U.K.

Aug. 23, 1996

Phase I pharmacokinetic study of asulacrine initiated

Aug. 23, 1996

Japanese investigators describe antileukemia activity of drupangtonine

Aug. 23, 1996

Taiho discloses antitumor nucleoside drugs

Aug. 23, 1996

Somatix in-licenses Salk gene transfer technology

Aug. 16, 1996

StressGen licenses cancer gene therapy technology from MRC

Aug. 16, 1996

Somatix issued patent on glioma gene therapy

Aug. 16, 1996

Advanced Therapies, Genetic Therapy collaborate on gene therapy

Aug. 16, 1996

Kyorin, Sagami report antineoplastic acrylamides

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026